XML 15 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Activities    
Net income $ 2,594,000 $ 4,118,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 402,000 412,000
Reversal of provision for credit losses (86,000) (1,805,000)
Net (gain) loss on calls and sales of debt and equity securities (377,000) 465,000
Net unrealized loss (gain) on equity securities 30,000 (57,000)
Net gain on sale of loans (15,000) (6,000)
Proceeds from sales of residential mortgages held-for-sale 801,000 388,000
Origination of residential mortgages held-for-sale (237,000) (770,000)
Increase in cash surrender value of bank-owned life insurance (94,000) (86,000)
Stock-based compensation expense 37,000 20,000
Deferred income tax (benefit) expense (102,000) 284,000
Net increase (decrease) in income taxes payable 194,000 (284,000)
Net (increase) decrease in accrued interest receivable (82,000) 1,613,000
Fair value remeasurements on interest rate swap 74,000  
Amortization of mortgage servicing rights and change in valuation allowance 12,000 11,000
Net amortization of premiums and discounts on investment securities 369,000 482,000
Net (decrease) increase in accrued interest payable (1,488,000) 456,000
Operating lease payments (157,000) (156,000)
Increase in other assets (323,000) (343,000)
Increase (decrease) in other liabilities 53,000 (663,000)
Net cash provided by operating activities 1,605,000 4,079,000
Investing Activities    
Proceeds from payments, maturities and calls of investments available-for-sale 11,338,000 10,210,000
Proceeds from the sale of investments available-for-sale 0 9,081,000
Proceeds from the sale of equity securities 1,210,000 709,000
Purchases of investments available-for-sale (2,967,000)  
Purchases of equity securities (1,170,000) (712,000)
Proceeds from redemption of investment in restricted stock   4,944,000
Purchases of restricted stock   (1,849,000)
Net (increase) decrease in loans (29,104,000) 27,961,000
Net purchases of premises and equipment (281,000) (115,000)
Redemption of Bank Owned Life Insurance investment 341,000  
Net cash (used in) provided by investing activities (20,633,000) 50,229,000
Financing Activities    
Net increase (decrease) in non-interest bearing deposits 3,162,000 (19,590,000)
Net increase in interest-bearing deposits 44,313,000 25,811,000
Net decrease in short-term borrowings (39,006,000) (51,135,000)
Repayment of long-term debt   (10,000,000)
Cash dividends paid, net of reinvestment (1,198,000) (1,151,000)
Proceeds from issuance of common stock 63,000 59,000
Net cash provided by (used in) financing activities 7,334,000 (56,006,000)
Decrease in cash and cash equivalents (11,694,000) (1,698,000)
Cash and cash equivalents at beginning of year 62,657,000 15,899,000
Cash and cash equivalents at end of period 50,963,000 14,201,000
Supplemental Cash Flow Disclosures    
Interest paid 10,889,000 4,590,000
Net income taxes paid 571,000 1,123,000
Non-cash transactions:    
Cumulative change in accounting principal   857,000
Unsettled trades for matured securities $ 1,500,000  
Right-of-use assets obtained in exchange for new operating lease liabilities   $ 369,000